Kestra Medical Technologies Cash Flow Statement
NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD
26.98+1.21 (+4.70%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kestra Medical Technologies free cash flow
In fiscal 2026, Kestra Medical Technologies generated -$81.7 million of operating cash flow and spent $34.9 million on capital expenditures. That left free cash flow of -$116.6 million, a free-cash-flow margin of -122.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Kestra Medical Technologies cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-04-30 | FY 20252025-04-30 | FY 20242024-04-30 |
|---|---|---|---|
| Net Income | -131.61M | -113.81M | -94.12M |
| Net Income growth (YoY) | — | — | — |
| Depreciation & Amortization | 8.71M | 7.97M | 11.56M |
| Stock-Based Compensation | 33.64M | 24.27M | 1.49M |
| Change in Working Capital | -5.32M | -7.79M | 5.17M |
| Operating Cash Flow | -81.70M | -77.61M | -72.23M |
| Capital Expenditures | -34.89M | -22.94M | -12.23M |
| Investing Cash Flow | -203.28M | -23.31M | -12.23M |
| Debt Issued | — | — | 45.00M |
| Debt Repaid | — | — | -39.12M |
| Financing Cash Flow | 147.09M | 330.26M | 77.72M |
| Net Change in Cash | -137.88M | 229.35M | -6.74M |
| Free Cash Flow | -116.59M | -100.54M | -84.46M |
This table shows 3 annual periods of Kestra Medical Technologies's cash flow statement, from FY 2026 back to FY 2024, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KMTS's reporting calendar. What is a cash flow statement?